Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Expression pattern of ISL-1, TTF-1 and PAX5 in olfactory neuroblastoma.

Czapiewski P, Gorczyński A, Haybaeck J, Okoń K, Reszeć J, Skrzypczak W, Dzierżanowski J, Kunc M, Karczewska J, Biernat W.

Pol J Pathol. 2016 Jun;67(2):130-5.

2.

Expression of SOX11, PAX5, TTF-1 and ISL-1 in medulloblastoma.

Czapiewski P, Gorczynski A, Radecka K, Wiewiora C, Haybaeck J, Adam P, Fend F, Zakrzewska M, Zakrzewski K, Liberski PP, Biernat W.

Pathol Res Pract. 2016 Nov;212(11):965-971. doi: 10.1016/j.prp.2016.08.006. Epub 2016 Aug 11.

PMID:
27623204
3.

Calretinin staining facilitates differentiation of olfactory neuroblastoma from other small round blue cell tumors in the sinonasal tract.

Wooff JC, Weinreb I, Perez-Ordonez B, Magee JF, Bullock MJ.

Am J Surg Pathol. 2011 Dec;35(12):1786-93. doi: 10.1097/PAS.0b013e3182363b78.

PMID:
22020045
4.

Frequent expression of somatostatin receptor 2a in olfactory neuroblastomas: a new and distinctive feature.

Czapiewski P, Kunc M, Gorczyński A, Haybaeck J, Okoń K, Reszec J, Lewczuk A, Dzierzanowski J, Karczewska J, Biernat W, Turri-Zanoni M, Castelnuovo P, Taverna C, Franchi A, La Rosa S, Sessa F, Klöppel G.

Hum Pathol. 2018 Sep;79:144-150. doi: 10.1016/j.humpath.2018.05.013. Epub 2018 May 25.

PMID:
29807052
5.

Expression of the human Achaete-scute 1 gene in olfactory neuroblastoma (esthesioneuroblastoma).

Carney ME, O'Reilly RC, Sholevar B, Buiakova OI, Lowry LD, Keane WM, Margolis FL, Rothstein JL.

J Neurooncol. 1995 Oct;26(1):35-43.

PMID:
8583243
6.

The clinicopathological spectrum of olfactory neuroblastoma and sinonasal neuroendocrine neoplasms: Refinements in diagnostic criteria and impact of multimodal treatments on survival.

Turri-Zanoni M, Maragliano R, Battaglia P, Giovannardi M, Antognoni P, Lombardi D, Morassi ML, Pasquini E, Tarchini P, Asioli S, Foschini MP, Sessa F, Nicolai P, Castelnuovo P, La Rosa S.

Oral Oncol. 2017 Nov;74:21-29. doi: 10.1016/j.oraloncology.2017.09.010.

PMID:
29103747
7.

[Clinicopathologic study of sinonasal teratocarcinosarcoma and its contrast with olfactory neuroblastoma].

Li X, Liu HG, Xie XJ, Han YD, Li M.

Zhonghua Bing Li Xue Za Zhi. 2008 Jul;37(7):458-64. Chinese.

PMID:
19035117
8.

The cytologic features of sinonasal undifferentiated carcinoma and olfactory neuroblastoma.

Bellizzi AM, Bourne TD, Mills SE, Stelow EB.

Am J Clin Pathol. 2008 Mar;129(3):367-76. doi: 10.1309/C00WN1HHJ9AMBJVT.

PMID:
18285258
9.

TTF-1 and PAX5 Are Frequently Expressed in Combined Merkel Cell Carcinoma.

Czapiewski P, Majewska H, Kutzner H, Kazakov D, Renkielska A, Biernat W.

Am J Dermatopathol. 2016 Jul;38(7):513-6. doi: 10.1097/DAD.0000000000000464.

PMID:
27322785
10.

Olfactory neuroblastoma (esthesioneuroblastoma) and esthesioneuroepithelioma: histologic and immunohistochemical study.

Taraszewska A, Czorniuk-Sliwa A, Dambska M.

Folia Neuropathol. 1998;36(2):81-6.

PMID:
9757618
11.

Comprehensive Molecular Profiling of Olfactory Neuroblastoma Identifies Potentially Targetable FGFR3 Amplifications.

Lazo de la Vega L, McHugh JB, Cani AK, Kunder K, Walocko FM, Liu CJ, Hovelson DH, Robinson D, Chinnaiyan AM, Tomlins SA, Harms PW.

Mol Cancer Res. 2017 Nov;15(11):1551-1557. doi: 10.1158/1541-7786.MCR-17-0135. Epub 2017 Aug 3.

12.

Expression of bcl-2 is associated with microvessel density in olfactory neuroblastoma.

Diensthuber M, Potinius M, Rodt T, Stan AC, Welkoborsky HJ, Samii M, Schreyögg J, Lenarz T, Stöver T.

J Neurooncol. 2008 Sep;89(2):131-9. doi: 10.1007/s11060-008-9602-9. Epub 2008 Apr 23.

PMID:
18431543
13.

Activation of sonic hedgehog signaling pathway in olfactory neuroblastoma.

Mao L, Xia YP, Zhou YN, Dai RL, Yang X, Wang YJ, Duan SJ, Qiao X, Mei YW, Hu B.

Oncology. 2009;77(3-4):231-43. doi: 10.1159/000236047. Epub 2009 Sep 7.

PMID:
19738389
14.

Comprehensive molecular profiling of advanced/metastatic olfactory neuroblastomas.

Topcagic J, Feldman R, Ghazalpour A, Swensen J, Gatalica Z, Vranic S.

PLoS One. 2018 Jan 11;13(1):e0191244. doi: 10.1371/journal.pone.0191244. eCollection 2018.

15.

Olfactory neuroblastoma in dogs and cats--a histological and immunohistochemical analysis.

Brosinski K, Janik D, Polkinghorne A, Von Bomhard W, Schmahl W.

J Comp Pathol. 2012 Feb-Apr;146(2-3):152-9. doi: 10.1016/j.jcpa.2011.06.002. Epub 2011 Jul 23.

PMID:
21783199
16.

[Olfactory neuroblastoma with unusual structures: a clinical pathologic study].

Yao Q, Yue CL, Lü ZC, Han YD, Liu HG.

Zhonghua Bing Li Xue Za Zhi. 2009 Mar;38(3):163-8. Chinese.

PMID:
19575850
17.

Neuroendocrine Neoplasms of the Sinonasal Tract: Neuroendocrine Carcinomas and Olfactory Neuroblastoma.

Shah K, Perez-Ordóñez B.

Head Neck Pathol. 2016 Mar;10(1):85-94. doi: 10.1007/s12105-016-0696-7. Epub 2016 Feb 1. Review.

18.

Cytopathologic features of olfactory neuroblastoma.

Mahooti S, Wakely PE Jr.

Cancer. 2006 Apr 25;108(2):86-92.

19.

Olfactory Neuroblastoma with Divergent Differentiation: An Unusual Histologic Finding in a Rare Tumor.

Meyer C, Hamersley ERS, Manosalva RE, Torske K, McIntyre N, Mitchell A.

Head Neck Pathol. 2017 Dec;11(4):531-536. doi: 10.1007/s12105-017-0781-6. Epub 2017 Feb 6.

20.

Absence of EWS/FLI1 fusion in olfactory neuroblastomas indicates these tumors do not belong to the Ewing's sarcoma family.

Kumar S, Perlman E, Pack S, Davis M, Zhang H, Meltzer P, Tsokos M.

Hum Pathol. 1999 Nov;30(11):1356-60.

PMID:
10571517

Supplemental Content

Support Center